Generic name |
tocilizumab |
---|---|
Strength |
162 mg/0.9 mL |
Form |
pre-filled syringe |
Special Authority criteria |
Approval period |
---|---|
For the treatment of giant cell arteritis (GCA), according to criteria detailed in Special Authority Request form HLTH 5496 and when prescribed by a rheumatologist or ophthalmologist |
1 year |